[go: up one dir, main page]

PL3458046T3 - Triglicerydy o średniej długości łańcucha do leczenia zwyrodnieniowej choroby zastawki mitralnej u zwierząt towarzyszących - Google Patents

Triglicerydy o średniej długości łańcucha do leczenia zwyrodnieniowej choroby zastawki mitralnej u zwierząt towarzyszących

Info

Publication number
PL3458046T3
PL3458046T3 PL17727386T PL17727386T PL3458046T3 PL 3458046 T3 PL3458046 T3 PL 3458046T3 PL 17727386 T PL17727386 T PL 17727386T PL 17727386 T PL17727386 T PL 17727386T PL 3458046 T3 PL3458046 T3 PL 3458046T3
Authority
PL
Poland
Prior art keywords
treatment
medium
mitral valve
companion animals
chain triglycerides
Prior art date
Application number
PL17727386T
Other languages
English (en)
Inventor
Qinghong LI
Dorothy P. Laflamme
Brittany Vester BOLER
Xui XU
Sandeep Bhatnagar
Original Assignee
Société des Produits Nestlé S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société des Produits Nestlé S.A. filed Critical Société des Produits Nestlé S.A.
Publication of PL3458046T3 publication Critical patent/PL3458046T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17727386T 2016-05-20 2017-05-19 Triglicerydy o średniej długości łańcucha do leczenia zwyrodnieniowej choroby zastawki mitralnej u zwierząt towarzyszących PL3458046T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662339436P 2016-05-20 2016-05-20
PCT/IB2017/052981 WO2017199223A1 (en) 2016-05-20 2017-05-19 Nutritional compositions for cardciac protection in companion animals
EP17727386.9A EP3458046B1 (en) 2016-05-20 2017-05-19 Medium-chain triglycerides for the treatment of degenerative mitral valve disease in companion animals

Publications (1)

Publication Number Publication Date
PL3458046T3 true PL3458046T3 (pl) 2021-07-05

Family

ID=58993169

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17727386T PL3458046T3 (pl) 2016-05-20 2017-05-19 Triglicerydy o średniej długości łańcucha do leczenia zwyrodnieniowej choroby zastawki mitralnej u zwierząt towarzyszących

Country Status (14)

Country Link
US (1) US20170332686A1 (pl)
EP (1) EP3458046B1 (pl)
JP (1) JP6920343B2 (pl)
CN (1) CN109069465B (pl)
AU (1) AU2017267615B2 (pl)
BR (1) BR112018072064B8 (pl)
CL (1) CL2018003075A1 (pl)
ES (1) ES2851923T3 (pl)
HU (1) HUE053622T2 (pl)
MX (1) MX388553B (pl)
NZ (1) NZ746681A (pl)
PL (1) PL3458046T3 (pl)
RU (1) RU2744134C2 (pl)
WO (1) WO2017199223A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018219877A1 (en) * 2017-05-29 2018-12-06 Nestec S.A. Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
US10973244B2 (en) 2017-11-17 2021-04-13 Hills Pet Nutrition, Inc. Compositions comprising omega-3 polyunsaturated and medium chain fatty acids
ES2992080T3 (es) * 2018-06-07 2024-12-09 Nestle Sa Métodos y composiciones para incrementar los cuerpos cetónicos en animales
EP4316477A1 (en) * 2018-08-22 2024-02-07 The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone Methods for treating cardiac valve disease
CN109007397A (zh) * 2018-08-23 2018-12-18 广东仁源生物科技有限公司 一种可以改善小鼠心脏形态结构与功能的饲料组合物及其制备方法
AU2019415009B2 (en) * 2018-12-27 2025-06-05 Societe Des Produits Nestle Sa Compositions and methods for diagnosing and treating degenerative mitral valve disease in a canine
BR112021015145A2 (pt) * 2019-02-01 2021-09-28 Mars, Incorporated Composição alimentar felina
JP2022524491A (ja) * 2019-03-22 2022-05-06 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 中鎖トリグリセリド（ｍｃｔ）からのケトン産生を増加させるために食前にｍｃｔの投与を用いる方法
CA3140992A1 (en) * 2019-05-31 2020-12-03 Societe Des Produits Nestle Sa Mct-based nutrition blend for providing health benefits in animals
JP2022534665A (ja) * 2019-05-31 2022-08-03 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物において健康効果をもたらすためのｍｃｔベースの栄養ブレンド
GB201908111D0 (en) * 2019-06-06 2019-07-24 Mars Inc Modulation of the oral microbiota
CN116634882A (zh) * 2020-12-22 2023-08-22 希尔氏宠物营养品公司 宠物食品组合物
KR102733841B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 눈 건강 개선용 간식 및 이의 제조방법
KR102733843B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 피부 건강 개선용 간식 및 이의 제조방법
KR102733845B1 (ko) * 2021-11-10 2024-11-27 문창민 반려동물의 무기력증, 식욕부진, 및 불안 장애 개선용 간식 및 이의 제조방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
US7514107B2 (en) * 2002-03-21 2009-04-07 Mars, Incorporated Treatment of diseases involving defective gap junctional communication
JP2005047851A (ja) * 2003-07-29 2005-02-24 Nisshin Pharma Inc ユビデカレノン含有組成物
CA2533590C (en) * 2003-09-05 2013-03-12 Hill's Pet Nutrition, Inc. Composition for animal consumption
CN101189514B (zh) * 2004-08-30 2013-05-29 希尔氏宠物营养品公司 基于基因组的饮食设计
US7595079B2 (en) * 2005-07-08 2009-09-29 Bomac Vets Plus, Inc. Nutritional conjunctive support therapy for recovery in animals following stress or illness
EP1988971B1 (en) * 2005-12-15 2018-02-28 Nestec S.A. Compositions and methods for preserving brain function
EP2044930A1 (en) * 2007-10-01 2009-04-08 Nestec S.A. Composition for controlling lipase catalyzed reactions
CA2710211C (en) * 2007-12-21 2013-09-10 Hill's Pet Nutrition, Inc. Pet food composition
JP5513852B2 (ja) * 2009-11-05 2014-06-04 花王株式会社 犬の僧帽弁閉鎖不全症及び／又は三叉弁閉鎖不全の発症リスク低減方法
WO2012037328A2 (en) * 2010-09-17 2012-03-22 Maine Natural Health, Inc. Compositions containing omega-3 oil with an anti-inflammatory agent and uses thereof
JP2014511890A (ja) * 2011-04-18 2014-05-19 ネステク ソシエテ アノニム α−ＨＩＣＡ及びα−ケトグルタル酸を含有する栄養組成物
FR2982460B1 (fr) * 2011-11-14 2016-08-05 Virbac Sa Produits pour administration orale comprenant des extraits de grenade punica granatum, destines a un animal de compagnie, et ses applications
WO2014090842A1 (en) * 2012-12-14 2014-06-19 Boehringer Ingelheim Vetmedica Gmbh Funny current (if) inhibitors for use in a method of treating and preventing heart disease in canine
JP2014210761A (ja) * 2013-04-05 2014-11-13 株式会社シバヤギ 抗イヌｎ末端プロ心房性ナトリウム利尿ペプチド抗体ならびにそれを用いた免疫学的測定方法、および免疫学的測定用キット
EP3004376B1 (en) * 2013-06-03 2018-05-09 Nestec S.A. Methods for diagnosing chronic valvular disease
EP3019024B1 (en) * 2013-06-28 2017-02-01 Nestec S.A. Compositions and methods for enhancing exercise performance

Also Published As

Publication number Publication date
EP3458046A1 (en) 2019-03-27
EP3458046B1 (en) 2021-01-13
CL2018003075A1 (es) 2018-12-07
AU2017267615A1 (en) 2018-10-18
CN109069465B (zh) 2021-08-17
ES2851923T3 (es) 2021-09-09
US20170332686A1 (en) 2017-11-23
HUE053622T2 (hu) 2021-07-28
JP6920343B2 (ja) 2021-08-18
MX388553B (es) 2025-03-20
AU2017267615B2 (en) 2022-03-17
CN109069465A (zh) 2018-12-21
JP2019521646A (ja) 2019-08-08
NZ746681A (en) 2022-07-01
WO2017199223A1 (en) 2017-11-23
CA3021169A1 (en) 2017-11-23
BR112018072064B8 (pt) 2022-08-23
BR112018072064B1 (pt) 2022-07-26
RU2018145067A3 (pl) 2020-09-11
RU2744134C2 (ru) 2021-03-03
BR112018072064A2 (pt) 2019-02-12
RU2018145067A (ru) 2020-06-22
MX2018014083A (es) 2019-04-04

Similar Documents

Publication Publication Date Title
PL3458046T3 (pl) Triglicerydy o średniej długości łańcucha do leczenia zwyrodnieniowej choroby zastawki mitralnej u zwierząt towarzyszących
IL273550A (en) Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the I148M variant of PNPLA3
IL264049A (en) Compounds, preparations and methods for treating the disease
PL3865506T3 (pl) Białko fuzyjne do zastosowania w leczeniu choroby hvg
IL264156A (en) Compounds, preparations and methods for treating the disease
IL252943A0 (en) Sunitinib formulations and methods of using them for the treatment of eye diseases
ZA201606158B (en) Treatment of metabolic disorders in equine animals
IL266047A (en) Methods and preparations for the treatment of Fabry disease
GB201504432D0 (en) Materials and methods for diagnosis and treatment of alzheimers disease
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
IL260684B (en) Treatment for modulating gut microbiota
EP3182989A4 (en) Methods and compositions for the prevention and treatment of disease
EP3130582B8 (en) Compound having immune disease treatment effect and use thereof
EP3228221A4 (en) Bed for promoting growth and relaxing joints and muscles
HUE051527T2 (hu) Muszkarin-antagonisták és kombinációik légúti betegség lovakban történõ kezelésére
SMT202300260T1 (it) Composti a base di indolinoni e loro utilizzo nel trattamento di patologie fibrotiche
EP3137063A4 (en) Treatment of crohn's disease with delayed-release 6-mercaptopurine
GB201703767D0 (en) Arrangement for the treatment of aquaculture fish
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
EP3119387A4 (en) Compositions for the treatment of dermatological diseases and disorders
LT3229790T (lt) Kompozicijos, apimančios vidutinės grandinės trigliceridus, skirtos panaudoti epilepsijos gydyme
IL261477B (en) A method for increasing the effects of isoptamide for controlling diseases in plants and a method for controlling diseases in plants
EP3162377A4 (en) Use of -asarone in preparing drugs for preventing and treating alzheimer's disease
IL257342A (en) Lisobactin for use in the treatment of udder inflammation in cattle
PT3471788T (pt) Prótese biológica destinada ao tratamento de hérnias paraestomais